Bagsværd, Denmark, 13 November 2024 - This company announcement discloses the data of the transaction(s) made in Novo Nordisk ...
Novo Nordisk A/S (NVO) on Wednesday reported third-quarter net income of $4.02 billion. On a per-share basis, the Bagsvaerd, Denmark-based company said it had profit of 90 cents. The results fell ...
Novo Nordisk's blockbuster drugs Ozempic and Wegovy have slimmed down Hollywood stars and millions of non-celebrities ...
Bagsværd, Denmark, 8 November 2024 - The execution of Novo Nordisk A/S' overall share repurchase programme for 2024 of DKK 20 ...
Novo Holdings is the controlling shareholder of Danish drugmaker Novo Nordisk (NOVOb.CO), opens new tab, whose profits from ...
Novo Nordisk today announced the headline results from part 1 of the ongoing ESSENCE trial, a pivotal phase 3, 240-week, ...
Novo Nordisk, the pharma giant behind Ozempic and Wegovy, has surprising love story origins. The founders, a married couple, ...